Contrast Enhanced Ultrasound, Endoleak Detection Following EVAR v1.3

Abdominal Aortic Aneurysm Clinical Trial

Official title:

Contrast Enhanced Ultrasound Endoleak Detection Compared To Time-Resolved Computer Tomography Angiography in High Risk Endovascular Aneurysm Repair (EVAR) Surveillance Patients.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02688751
• Other study ID #: 5083
• Secondary ID: 15/NW/0908
• Status: Completed
• Start date: January 20, 2016
• Est. completion date: March 20, 2018

Study information

• Verified date: September 2016
• Source: Liverpool University Hospitals NHS Foundation Trust
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

A single site cross-sectional comparison of paired diagnostic imaging modalities.

This study will show the sensitivity and specificity of CEUS in detecting the various types of endoleaks, in comparison to tCTA, following EVAR. It will collect data to allow comparison of diagnostic accuracy across modalities including CDU, CEUS and tCTA. It will collect time taken to perform the various types of scan, to allow healthcare costs to be calculated for each imaging modality.

Description:

This study will show the sensitivity and specificity of CEUS in detecting the various types of endoleaks, in comparison to tCTA, following EVAR. It will collect data to allow comparison of diagnostic accuracy across modalities including CDU, CEUS and tCTA. It will collect time taken to perform the various types of scan, to allow healthcare costs to be calculated for each imaging modality.

Collected data will be analysed regarding two novel hypothesised methods of using CEUS information:

The first is recording temporal delay between contrast in graft and contrast in endoleak to define endoleak type. Potentially this could be used as a faster method of defining endoleak type in a surveillance programme.

The second is to identify/refute correlation between CEUS contrast to appear in endoleak vs tCTA contrast to appear in endoleak. If an association can be established, CEUS timings could potentially then be used to time 'standard' CTA phases to improve CTAs diagnostic accuracy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: March 20, 2018
• Est. primary completion date: March 20, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Aged 18 or over

2. Able to give informed consent

3. Undergone an EVAR of infra-renal abdominal aortic aneurysm

4. Planned for CTA of EVAR

Exclusion Criteria:

1. Unable to receive CTA Contrast Allergy, Insufficient renal function for standard outpatient contrast study (eGFR <45) Overactive thyroid gland

2. Unable to receive CEUS contrast Previous reaction to Sonovue (Ultrasound Contrast) Allergy to sulphur hexafluoride (used in electrical industry in circuit breakers, switch gears & electrical equipment) Recent acute coronary syndrome or unstable angina, typical angina at rest or frequent or repeated angina/chest pain - all within previous 7 days Recent coronary intervention

3. Previous embolization of artery in region of EVAR (affects imaging quality)

4. BMI >30 (affects imaging quality)

Related Conditions & MeSH terms

• Abdominal Aortic Aneurysm
• Aneurysm
• Aortic Aneurysm
• Aortic Aneurysm, Abdominal
• Endoleak

Intervention

Radiation:
• time-resolved CT Angiography
A multi-phase contrast CT

Procedure:
• Contrast Enhanced Ultrasound
A ultrasound scan with micro bubble contrast injection

Locations

Country	Name	City	State
United Kingdom	Royal Liverpool Hospital	Liverpool	Merseyside

Sponsors (1)

Lead Sponsor	Collaborator
Liverpool University Hospitals NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Ability to detect type I/III endoleak on CEUS as defined by presence/absence on tCTA	Will be presented as a Sensitivity & specificity	Immediate
Secondary	Ability to detect type II endoleak on CEUS as defined by presence/absence on tCTA	Will be presented as a Sensitivity & specificity	Immediate
Secondary	Ability to predict secondary intervention on CEUS as defined by patients proceeding to secondary intervention	Will be presented as a Sensitivity & specificity	Immediate
Secondary	Confirm / refute association between temporal delay measured on CEUS and endoleak type as defined by tCTA, using the framework of general linear regression.	Temporal delay is the time difference between contrast arriving in the stent graft and contrast arriving in the endoleak on CEUS	Immediate
Secondary	Establish association between "CEUS contrast in endoleak" to "tCTA contrast in endoleak" by general linear regression analysis of timings recorded during CEUS & tCTA.		Immediate
Secondary	Ability to predict secondary intervention of CDU, CEUS and tCTAas defined by patients proceeding to secondary intervention	Will be presented as a Sensitivity & specificity	6 months
Secondary	Time taken for CDU, CEUS & tCTA scans to be performed as measured by observer.	Used to calculate total resource utilisation by individual scan types.	Immediate